Sprint Bioscience
Anne-Marie Wenthzel has a diverse background in the field of biotechnology, spanning from clinical research to business development. Anne-Marie holds a Ms. Sci. and Ph. Lic. in Microbiology and Molecular Biology from Stockholm University. With over two decades of experience, Anne-Marie has held various roles such as Chief Business Officer at Sprint Bioscience, CEO at Miterovia, and Key Account Manager at PerkinElmer. Throughout their career, Anne-Marie has also worked as an Associate Scientist, Product Specialist, and Clinical Research trainee, showcasing their expertise in both scientific research and business management.
This person is not in any offices
Sprint Bioscience
Sprint Bioscience is an innovative company focused on early-stage drug development, providing novel drug candidates within the cancer field.